Hims & Hers Health, Inc.

Equities

HIMS

US4330001060

Healthcare Facilities & Services

Market Closed - Nyse Other stock markets 04:00:02 2024-04-26 pm EDT			5-day change	1st Jan Change
12.5 ^USD	+1.87%		+5.04%	+40.45%

Apr. 26	Seaport Global Starts Hims & Hers Health With Buy Rating	MT
Apr. 16	Jefferies Downgrades Hims & Hers Health to Hold From Buy, Cuts Price Target to $15 From $17	MT

Hims & Hers Health, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023

February 26, 2024 at 04:05 pm EST

Hims & Hers Health, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 872 million compared to USD 526.92 million a year ago. Net loss was USD 23.55 million compared to USD 65.68 million a year ago.

Basic loss per share from continuing operations was USD 0.11 compared to USD 0.32 a year ago. Diluted loss per share from continuing operations was USD 0.11 compared to USD 0.32 a year ago.

Latest news about Hims & Hers Health, Inc.

Seaport Global Starts Hims & Hers Health With Buy Rating	Apr. 26	MT
Jefferies Downgrades Hims & Hers Health to Hold From Buy, Cuts Price Target to $15 From $17	Apr. 16	MT
Canaccord Genuity Initiates Coverage on Hims & Hers Health With Buy Rating, $20 Price Target	Apr. 10	MT
Hims & Hers Appoints Christopher Payne as Newest Board Member	Apr. 03	CI
Hims & Hers Health Insider Sold Shares Worth $823,055, According to a Recent SEC Filing	Mar. 22	MT
Hims & Hers Health Insider Sold Shares Worth $965,016, According to a Recent SEC Filing	Mar. 15	MT
Hims & Hers Health Insider Sold Shares Worth $500,107, According to a Recent SEC Filing	Mar. 08	MT
Hims & Hers Health Insider Sold Shares Worth $685,288, According to a Recent SEC Filing	Mar. 05	MT
Hims & Hers Health Insider Sold Shares Worth $5,032,142, According to a Recent SEC Filing	Mar. 04	MT
Tigress Financial Boosts Price Target on Hims & Hers Health to $19 From $15, Cites Move to Accelerated Growth Phase, Keeps Buy Rating	Mar. 01	MT
Hims & Hers Health Shares Jump After Q4 Beat	Feb. 27	MT
Piper Sandler Adjusts Price Target on Hims & Hers Health to $11 From $9, Maintains Neutral Rating	Feb. 27	MT
Deutsche Bank Adjusts Hims & Hers Health Price Target to $14 From $8, Maintains Hold Rating	Feb. 27	MT
Truist Securities Adjusts Price Target on Hims & Hers Health to $13 From $10, Keeps Hold Rating	Feb. 27	MT
Social Buzz: Wallstreetbets Stocks Mostly Higher Pre-Bell Tuesday; Hims & Hers Health Set to Gain, Intuitive Machines to Decline	Feb. 27	MT
Transcript : Hims & Hers Health, Inc., Q4 2023 Earnings Call, Feb 26, 2024	Feb. 26
Hims & Hers Health Q4 Swings to Net Income, Revenue Rises; Sets Q1, 2024 Outlook; Shares Surge	Feb. 26	MT
Earnings Flash (HIMS) HIMS & HERS HEALTH Posts Q4 Revenue $246.6M, vs. Street Est of $246.5M	Feb. 26	MT
Hims & Hers Health, Inc. Provides Earnings Guidance for the First Quarter and Full Year of 2024	Feb. 26	CI
Hims & Hers Health, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 26	CI
Hims & Hers Health, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 26	CI
Leerink Partners Initiates Coverage on Hims & Hers Health With Market Perform Rating, $10 Price Target	Feb. 26	MT
Hims & Hers Health, Inc. acquired PPDP.	Feb. 25	CI
Hims & Hers Names Dan Kenger as the Company?s First Chief Design Officer	Feb. 20	CI
Hims & Hers Health Insider Sold Shares Worth $2,511,317, According to a Recent SEC Filing	Feb. 15	MT

Chart Hims & Hers Health, Inc.

Duration

Period

More charts

Company Profile

Hims & Hers Health, Inc. provides a consumer-first platform, which helps customers to fulfill their health and wellness needs. The Companyâs digital platform offers access to a provider network, a clinically focused electronic medical record system, digital prescriptions and cloud pharmacy fulfillment. Its digital platform provides access to treatments for a range of conditions, including those related to sexual health, hair loss, dermatology, mental health and weight loss. The Company connects patients to licensed healthcare professionals who can prescribe medications when appropriate. In addition, the Company also offers access to a range of health and wellness products designed to meet individual needs, which includes curated prescription and non-prescription products. Its Hims & Hers mobile application enables consumers to access a range of educational programs, wellness content, community support and other services that promote lifelong health and wellness.

Sector

Healthcare Facilities & Services

Calendar

2024-05-05 - Q1 2024 Earnings Release

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Hims & Hers Health, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

12.5 USD

Average target price

14.94 USD

Spread / Average Target

+19.54%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Telemedicine Services

	1st Jan change	Capi.
HIMS & HERS HEALTH, INC.	+40.45%	2.68B
TALKSPACE, INC.	+22.83%	527M
QDM INTERNATIONAL INC.	+42.77%	467M
AMERICAN WELL CORPORATION	-64.56%	156M
SHL TELEMEDICINE LTD.	-31.65%	85.12M

Telemedicine Services